Elanco Animal Health Incorporated
DE ˙ DB ˙ US28414H1032
€20,80 ↑0,04 (0,19%)
2026-06-05
HİSSE FİYATI
SecurityDE:5EA / Elanco Animal Health Incorporated
InstitutionFmr Llc
Latest Disclosed Ownership52,196,321 shares
Ownership 10.50%
Fmr Llc ownership in 5EA / Elanco Animal Health Incorporated

2026-02-05 - Fmr Llc has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 52,196,321 shares of Elanco Animal Health Incorporated (DE:5EA). This represents 10.5 percent ownership of the company. In their previous filing dated 2025-08-06 , Fmr Llc had reported owning 64,883,397 shares, indicating a decrease of -19.55 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2026-02-05 2026-02-05 13G/A 64,883,397 52,196,321 -19.55 10.50 -19.85
2025-08-06 2025-08-06 13G/A 49,541,123 64,883,397 30.97 13.10 31.00
2025-03-07 2025-03-07 13G/A 40,232,326 49,541,123 23.14 10.00 23.46
2025-02-12 2025-02-12 13G 40,232,326 8.10

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 50,925,366 -1,270,955 -2.43 1,218,644 3.17 0.0128
2026-02-17 2025-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 52,196,321 -13,161,059 -20.14 1,181,203 -10.26 0.0602
2025-11-13 2025-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 65,357,380 473,983 0.73 1,316,298 42.07 0.0684
2025-08-14 2025-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 64,883,397 11,024,724 20.47 926,535 63.84 0.0522
2025-05-12 2025-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 53,858,673 13,626,346 33.87 565,516 16.07 0.0361
2025-02-13 2024-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 40,232,327 37,022,891 1,153.56 487,213 933.41 0.0291
2024-11-13 2024-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 3,209,436 -228,450 -6.65 47,147 -4.96 0.0029
2024-08-13 2024-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 3,437,886 1,293,205 60.30 49,609 42.08 0.0032
2024-05-13 2024-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 2,144,681 1,889,906 741.79 34,915 819.78 0.0023
2024-02-13 2023-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 254,775 -159,609 -38.52 3,796 -18.49 0.0003
2023-11-13 2023-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 414,384 -882,302 -68.04 4,658 -64.30 0.0004
2023-08-11 2023-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 1,296,686 -426,459 -24.75 13,045 -19.47 0.0011
2023-08-11 2023-03-31 13F/A-1 ELANCO ANIMAL HEALTH COM 28414H103 1,723,145 -874,488 -33.66 16,198 -48.97 0.0015
2023-05-11 2023-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 1,723,145 -874,488 16,198 0.0003
2023-02-13 2022-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 2,597,633 1,582,231 155.82 31,743 151.93 0.0032
2022-11-10 2022-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 1,015,402 896,426 753.45 12,600 439.61 0.0013
2022-08-12 2022-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 118,976 -169,314 -58.73 2,335 -68.95 0.0002
2022-05-13 2022-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 288,290 15,216 5.57 7,521 -2.95 0.0006
2022-02-14 2021-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 273,074 -91,041 -25.00 7,750 -33.25 0.0006
2022-02-14 2021-09-30 13F/A-1 ELANCO ANIMAL HEALTH COM 28414H103 364,115 70,947 24.20 11,611 14.17 0.0009
2021-11-15 2021-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 364,115 70,947 11,611 0.0009
2021-08-13 2021-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 293,168 2,552 0.88 10,170 18.84 0.0008
2021-05-14 2021-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 290,616 -779 -0.27 8,558 -4.24 0.0007
2021-02-08 2020-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 291,395 -813,243 -73.62 8,937 -71.03 0.0008
2020-11-13 2020-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 1,104,638 -43,131 -3.76 30,852 25.32 0.0031
2020-08-24 2020-06-30 13F/A-1 ELANCO ANIMAL HEALTH COM 28414H103 1,147,769 287,193 33.37 24,619 27.77 0.0027
2020-08-13 2020-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 1,147,769 1,027,669 24,619 604.8168
2020-05-14 2020-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 860,576 366,556 74.20 19,268 32.44 0.0027
2020-02-07 2019-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 494,020 140,316 39.67 14,549 54.69 0.0016
2019-11-13 2019-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 353,704 -421,218 -54.36 9,405 -64.09 0.0011
2019-08-13 2019-06-30 13F ELANCO ANIMAL HEALTH COM 28414H103 774,922 -755,253 -49.36 26,192 -46.63 0.0031
2019-05-13 2019-03-31 13F ELANCO ANIMAL HEALTH COM 28414H103 1,530,175 -2,884,997 -65.34 49,073 -64.75 0.0059
2019-02-13 2018-12-31 13F ELANCO ANIMAL HEALTH COM 28414H103 4,415,172 1,131,504 34.46 139,210 21.51 0.0191
2018-11-09 2018-09-30 13F ELANCO ANIMAL HEALTH COM 28414H103 3,283,668 3,283,668 114,567 0.0129
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.